Monday, October 11, 2021

REUTERS: Delta does not appear to make children sicker; Secondary immune response stronger after infection than after shot

 

Reuters admits that a person's "Secondary Immune Response" is strong after a previous infection than after shot.

This is HUGE!

A "Secondary Immune Response" is the human bodies immune response to a disease it has been previously infected with.

In other words, your natural immune system is stronger than the vaccination.

And Reuters is admitting it here. Will Reuters be fact-checked? If so, by who?

Put this together with two other big stories from the past couple of days: 

1) Australia lifted their Stalinesque lockdown

2) The Airline/Traffic Controller showdown over Vaccine mandates

and it seems like something big is happening.

Is the Berlin Wall of COVID about to fall?

Mr. Fauci, TEAR DOWN THIS WALL!

From Reuters:

Oct 8 (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review. 
Delta variant does not appear to make children sicker The Delta variant of the coronavirus does not appear to cause more severe disease in children than earlier forms of the virus, a UK study suggests. 
Earlier this year, the research team found the Alpha variant of the virus did not appear to make children sicker than the so-called wild, or original, form of the virus, first seen in China. New data suggests that kids also do not get any sicker from Delta than they did from Alpha. ... 
Secondary immune response stronger after infection than vaccination 
In COVID-19 survivors, important components of the body's immune response called memory B cells continue to evolve and get stronger for at least several months, producing highly potent antibodies that can neutralize new variants of the virus, a new study has found. 
By comparison, vaccine-induced memory B cells are less robust, evolving for only a few weeks and never "learning" to protect against variants, researchers reported in a paper published on Thursday in Nature.

No comments: